A "systems medicine" approach to the study of non-alcoholic fatty liver disease

Salvatore Petta, Valerio Nobili, Ele Ferrannini, Marcello Mancini, Maurizia Rossana Brunetto, Carmela Loguercio, Ferruccio Bonino, Fabio Marra, Stefano Vella, Stefano Bellentani, Antonio Grieco, Gianluca Svegliati Baroni, Dante Romagnoli, Fabio Nascimbeni, Stefano Ballestri, Luca Valenti, Ester Vanni, Anna Prinster, Loreta Kondili, Barbara CocoElisabetta Bugianesi, Giovanni Targher, Luca Valenti, Luca Miele, Silvia Fargion, Amedeo Lonardo, Stefano Taddei, Federico Alessandro

Research output: Contribution to journalArticlepeer-review

55 Citations (Scopus)


The prevalence of fatty liver (steatosis) in the general population is rapidly increasing worldwide. The progress of knowledge in the physiopathology of fatty liver is based on the systems biology approach to studying the complex interactions among different physiological systems. Similarly, translational and clinical research should address the complex interplay between these systems impacting on fatty liver. The clinical needs drive the applications of systems medicine to re-define clinical phenotypes, assessing the multiple nature of disease susceptibility and progression (e.g. the definition of risk, prognosis, diagnosis criteria, and new endpoints of clinical trials). Based on this premise and in light of recent findings, the complex mechanisms involved in the pathology of fatty liver and their impact on the short- and long-term clinical outcomes of cardiovascular, metabolic liver diseases associated with steatosis are presented in this review using a new "systems medicine" approach. A new data set is proposed for studying the impairments of different physiological systems that have an impact on fatty liver in different subsets of subjects and patients.
Original languageEnglish
Pages (from-to)333-342
Number of pages10
JournalDigestive and Liver Disease
Publication statusPublished - 2016

All Science Journal Classification (ASJC) codes

  • Hepatology
  • Gastroenterology


Dive into the research topics of 'A "systems medicine" approach to the study of non-alcoholic fatty liver disease'. Together they form a unique fingerprint.

Cite this